PharVision Advisers LLC Makes New $226,000 Investment in Exponent, Inc. (NASDAQ:EXPO)

PharVision Advisers LLC bought a new position in shares of Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,537 shares of the business services provider’s stock, valued at approximately $226,000.

A number of other institutional investors have also made changes to their positions in EXPO. Barclays PLC lifted its position in shares of Exponent by 219.0% during the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after acquiring an additional 66,263 shares during the period. Inspire Investing LLC increased its holdings in Exponent by 25.4% in the 4th quarter. Inspire Investing LLC now owns 4,495 shares of the business services provider’s stock worth $401,000 after purchasing an additional 910 shares in the last quarter. KBC Group NV increased its holdings in Exponent by 62.4% in the 4th quarter. KBC Group NV now owns 2,274 shares of the business services provider’s stock worth $203,000 after purchasing an additional 874 shares in the last quarter. Pacer Advisors Inc. raised its position in shares of Exponent by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 7,574 shares of the business services provider’s stock worth $675,000 after acquiring an additional 180 shares during the last quarter. Finally, Caprock Group LLC raised its position in shares of Exponent by 13.2% during the fourth quarter. Caprock Group LLC now owns 3,712 shares of the business services provider’s stock worth $331,000 after acquiring an additional 434 shares during the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Price Performance

NASDAQ EXPO opened at $77.43 on Friday. The business has a 50 day simple moving average of $78.95 and a 200 day simple moving average of $87.37. Exponent, Inc. has a one year low of $73.37 and a one year high of $115.75. The stock has a market capitalization of $3.93 billion, a P/E ratio of 36.52 and a beta of 0.95.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million during the quarter, compared to analysts’ expectations of $134.63 million. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The company’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.59 earnings per share. Equities analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.55%. Exponent’s payout ratio is presently 58.54%.

Insider Buying and Selling at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the company’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Bradley A. James sold 2,694 shares of the business’s stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total value of $214,226.88. The disclosure for this sale can be found here. Corporate insiders own 2.10% of the company’s stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.